Cyclo Therapeutics reports FY resultsSeekingAlpha.com: All News • about 1 month ago
Cyclo Therapeutics reports FY results...
Share to Feed
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for...
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for...
Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a majority...
Cyclo Therapeutics (NASDAQ:CYTH Get Free Report) and Revolution Medicines (NASDAQ:RVMD Get Free Report) are both medical companies, but which is the better investment? We will...
Acorda Therapeutics (NASDAQ:ACOR Get Free Report) and Cyclo Therapeutics (NASDAQ:CYTH Get Free Report) are both small-cap medical companies, but which is the better stock? We will...
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for...
Cyclo Therapeutics (CYTH) has released an update. Cyclo Therapeutics, Inc. has been informed by Nasdaq's Office of General Counsel that it has rect...
Cyclo Therapeutics, Inc. (NASDAQ:CYTH Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest...